May 23, 2018
The 340B program continues to garner the attention of Congress and the Trump Administration. In a recent flurry of activity, the Senate Health, Education, Labor and Pensions (HELP) Committee held its second [...]
January 12, 2018
Three hearings before the House Energy and Commerce (E&C) Committee and its Oversight and Investigation Subcommittee[1] have culminated in an 80-page report (Report) containing the E&C Committee’s findings and review of the [...]
January 5, 2018
The closing months of 2017 saw a flurry of activity related to the 340B drug pricing program, both as a topic of legislative and regulatory actions, and the subject of litigation. The [...]
November 3, 2017
On November 1, 2017, the Centers for Medicare & Medicaid Services (CMS) finalized the Hospital Outpatient Prospective Payment System (HOPPS) Final Rule for 2018. The Final Rule retains a controversial proposal to [...]
October 17, 2017
On October 11, 2017, the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee convened a hearing on the use of 340B program savings by covered entities.[1] The subcommittee solicited [...]
October 17, 2017
HRSA has finalized its proposal to delay enforcement of its final rule imposing civil monetary penalties (CMPs) on manufacturers that overcharge 340B program covered entities until July 1, 2018.[1] The rule, which [...]
July 17, 2017
The Centers for Medicare and Medicaid Services (CMS) is poised to propose massive cuts to Medicare Part B reimbursement rates for hospitals and hospital-based grantees participating in the federal 340B drug discount [...]
June 8, 2017
All clients participating in the 340B Discount Drug Program (340B program) should watch carefully for state changes to Medicaid reimbursement for drugs. In 2016, the Centers for Medicare and Medicaid Services (CMS) [...]
June 5, 2017
HRSA has announced that its regulations authorizing the imposition of civil monetary penalties (CMPs) on manufacturers that overcharge 340B program covered entities will not take effect until October 1, 2017, at the [...]
June 1, 2017
The Health Resources and Services Administration (HRSA) urges 340B drug discount program covered entities to adequately monitor the program compliance of their contract pharmacy partners.[1] We recently learned that HRSA is sending [...]